Literature DB >> 24251857

Association of metabolite concentrations and water diffusivity in normal appearing brain tissue with glioma grade.

Andrew A Maudsley1, Bhaswati Roy2, Rakesh K Gupta2, Sulaiman Sheriff1, Rishi Awasthi2, Meng Gu3, Nuzhat Husain4, Sudipa Mohakud2, Sanjay Behari5, Daniel M Spielman3.   

Abstract

BACKGROUND AND
PURPOSE: Studies of brain tumors have identified altered tissue metabolism and water diffusion in MRI normal appearing tissue regions. In this retrospective study the relationship of these imaging measures with tumor grade in gliomas was investigated.
METHODS: MR spectroscopic imaging of whole brain and mean diffusivity (MD) measurements were obtained in subjects with untreated glioma and from normal control subjects. Mean metabolite values for N-acetylaspartate (NAA), total creatine (Cre), and total choline (Cho) were obtained in gray- and white-matter regions for the hemisphere contralateral to the tumor location, and MD values were obtained from contralateral normal-appearing white matter. Analyses tested for differences in mean values between subject groups while accounting for age.
RESULTS: Analysis demonstrated increased NAA/Cre and MD, and decreased Cho/NAA for all tumor grades relative to control values. Differences between tumor grades were also observed for NAA, NAA/Cre, and Cho/NAA. Abnormal values of water diffusion were also observed, but with only a weak association between alterations in diffusion and tissue metabolites.
CONCLUSIONS: This study supports previous observations of altered tissue metabolism and water diffusion in normal-appearing white matter while additionally finding differences of metabolite values in gray matter and an association with tumor grade.
Copyright © 2013 by the American Society of Neuroimaging.

Entities:  

Keywords:  1H MRSI; MRI diffusion; brain; glioma; normal tissue; spectroscopic imaging

Mesh:

Year:  2013        PMID: 24251857      PMCID: PMC4874645          DOI: 10.1111/jon.12063

Source DB:  PubMed          Journal:  J Neuroimaging        ISSN: 1051-2284            Impact factor:   2.486


  11 in total

1.  Whole-brain N-acetylaspartate spectroscopy and diffusion tensor imaging in patients with newly diagnosed gliomas: a preliminary study.

Authors:  M Inglese; S Brown; G Johnson; M Law; E Knopp; O Gonen
Journal:  AJNR Am J Neuroradiol       Date:  2006 Nov-Dec       Impact factor: 3.825

2.  Untreated glioblastoma multiforme: increased myo-inositol and glutamine levels in the contralateral cerebral hemisphere at proton MR spectroscopy.

Authors:  Kai Kallenberg; Hans C Bock; Gunther Helms; Klaus Jung; Arne Wrede; Jan-Hendrik Buhk; Alf Giese; Jens Frahm; Herwig Strik; Peter Dechent; Michael Knauth
Journal:  Radiology       Date:  2009-09-29       Impact factor: 11.105

3.  Assessing global invasion of newly diagnosed glial tumors with whole-brain proton MR spectroscopy.

Authors:  Benjamin A Cohen; Edmond A Knopp; Henry Rusinek; James S Babb; David Zagzag; Oded Gonen
Journal:  AJNR Am J Neuroradiol       Date:  2005-10       Impact factor: 3.825

4.  Quantitative MR imaging and spectroscopy of brain tumours: a step forward?

Authors:  Dita Wagnerova; Vit Herynek; Alberto Malucelli; Monika Dezortova; Josef Vymazal; Dusan Urgosik; Martin Syrucek; Filip Jiru; Antonin Skoch; Robert Bartos; Martin Sames; Milan Hajek
Journal:  Eur Radiol       Date:  2012-06-12       Impact factor: 5.315

5.  Disarrangement of fiber tracts and decline of neuronal density correlate in glioma patients--a combined diffusion tensor imaging and 1H-MR spectroscopy study.

Authors:  E Goebell; J Fiehler; X-Q Ding; S Paustenbach; S Nietz; O Heese; T Kucinski; C Hagel; M Westphal; H Zeumer
Journal:  AJNR Am J Neuroradiol       Date:  2006-08       Impact factor: 3.825

6.  Influence of brain tumors on the MR spectra of healthy brain tissue.

Authors:  M Busch; K Liebenrodt; S Gottfried; E Weiland; W Vollmann; S Mateiescu; S Winter; S Lange; H Sahinbas; J Baier; P van Leeuwen; D Grönemeyer
Journal:  Magn Reson Med       Date:  2011-01       Impact factor: 4.668

7.  Utility of multiparametric 3-T MRI for glioma characterization.

Authors:  Bhaswati Roy; Rakesh K Gupta; Andrew A Maudsley; Rishi Awasthi; Sulaiman Sheriff; Meng Gu; Nuzhat Husain; Sudipta Mohakud; Sanjay Behari; Chandra M Pandey; Ram K S Rathore; Daniel M Spielman; Jeffry R Alger
Journal:  Neuroradiology       Date:  2013-02-02       Impact factor: 2.804

8.  Mapping of brain metabolite distributions by volumetric proton MR spectroscopic imaging (MRSI).

Authors:  A A Maudsley; C Domenig; V Govind; A Darkazanli; C Studholme; K Arheart; C Bloomer
Journal:  Magn Reson Med       Date:  2009-03       Impact factor: 4.668

9.  Brain metabolomic profiles of lung cancer patients prior to treatment characterized by proton magnetic resonance spectroscopy.

Authors:  Helene Benveniste; Shaonan Zhang; Ruth A Reinsel; Haifang Li; Hedok Lee; Mario Rebecchi; William Moore; Christoffer Johansen; Douglas L Rothman; Thomas V Bilfinger
Journal:  Int J Clin Exp Med       Date:  2012-04-06

10.  Peritumoral brain regions in gliomas and meningiomas: investigation with isotropic diffusion-weighted MR imaging and diffusion-tensor MR imaging.

Authors:  James M Provenzale; Peter McGraw; Pradnya Mhatre; Alexander C Guo; David Delong
Journal:  Radiology       Date:  2004-06-23       Impact factor: 11.105

View more
  12 in total

Review 1.  Whole Brain ¹H-Spectroscopy: A Developing Technique for Advanced Analysis of Cerebral Metabolism.

Authors:  X-Q Ding; H Lanfermann
Journal:  Clin Neuroradiol       Date:  2015-07-09       Impact factor: 3.649

2.  Quantifying global-brain metabolite level changes with whole-head proton MR spectroscopy at 3T.

Authors:  Matthew S Davitz; William E Wu; Brian J Soher; James S Babb; Ivan I Kirov; Jeffrey Huang; Girish Fatterpekar; Oded Gonen
Journal:  Magn Reson Imaging       Date:  2016-08-28       Impact factor: 2.546

3.  Value of diffusion kurtosis imaging in assessing low-grade gliomas.

Authors:  Mohammed Z Goryawala; Deborah O Heros; Ricardo J Komotar; Sulaiman Sheriff; Efrat Saraf-Lavi; Andrew A Maudsley
Journal:  J Magn Reson Imaging       Date:  2018-03-23       Impact factor: 4.813

4.  The Distribution of Major Brain Metabolites in Normal Adults: Short Echo Time Whole-Brain MR Spectroscopic Imaging Findings.

Authors:  Xinnan Li; Kagari Abiko; Sulaiman Sheriff; Andrew A Maudsley; Yuta Urushibata; Sinyeob Ahn; Khin Khin Tha
Journal:  Metabolites       Date:  2022-06-14

5.  Increased diffusion in the normal appearing white matter of brain tumor patients: is this just tumor infiltration?

Authors:  Andrea Horváth; Gábor Perlaki; Arnold Tóth; Gergely Orsi; Szilvia Nagy; Tamás Dóczi; Zsolt Horváth; Péter Bogner
Journal:  J Neurooncol       Date:  2015-11-27       Impact factor: 4.130

6.  Global brain metabolic quantification with whole-head proton MRS at 3 T.

Authors:  Ivan I Kirov; William E Wu; Brian J Soher; Matthew S Davitz; Jeffrey H Huang; James S Babb; Mariana Lazar; Girish Fatterpekar; Oded Gonen
Journal:  NMR Biomed       Date:  2017-07-05       Impact factor: 4.044

7.  The Association between Whole-Brain MR Spectroscopy and IDH Mutation Status in Gliomas.

Authors:  Mohammed Goryawala; Efrat Saraf-Lavi; Natalia Nagornaya; Deborah Heros; Ricardo Komotar; Andrew A Maudsley
Journal:  J Neuroimaging       Date:  2019-12-23       Impact factor: 2.486

8.  T1-weighted and T2-weighted Subtraction MR Images for Glioma Visualization and Grading.

Authors:  Mohammed Goryawala; Bhaswati Roy; Rakesh K Gupta; Andrew A Maudsley
Journal:  J Neuroimaging       Date:  2020-11-30       Impact factor: 2.324

9.  Advanced magnetic resonance spectroscopic neuroimaging: Experts' consensus recommendations.

Authors:  Andrew A Maudsley; Ovidiu C Andronesi; Peter B Barker; Alberto Bizzi; Wolfgang Bogner; Anke Henning; Sarah J Nelson; Stefan Posse; Dikoma C Shungu; Brian J Soher
Journal:  NMR Biomed       Date:  2020-04-29       Impact factor: 4.044

Review 10.  Accelerated MR spectroscopic imaging-a review of current and emerging techniques.

Authors:  Wolfgang Bogner; Ricardo Otazo; Anke Henning
Journal:  NMR Biomed       Date:  2020-05-12       Impact factor: 4.044

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.